letrozole has been researched along with Hepatocellular Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Dika, I | 1 |
| Mayer, RJ | 1 |
| Venook, AP | 1 |
| Capanu, M | 1 |
| LaQuaglia, MP | 1 |
| Kobos, R | 1 |
| O'Neill, AF | 1 |
| Chou, JF | 1 |
| Ly, M | 1 |
| Ang, C | 1 |
| O'Reilly, EM | 1 |
| Gordan, JD | 1 |
| Abou-Alfa, GK | 1 |
1 trial available for letrozole and Hepatocellular Carcinoma
| Article | Year |
|---|---|
A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Estrogens; Ev | 2020 |